| Jay Schlumpberger, MD | |
|
795 El Camino Real, Palo Alto, CA 94301-2302 | |
| (650) 321-4121 | |
| Not Available |
| Full Name | Jay Schlumpberger |
|---|---|
| Gender | Male |
| Speciality | Family Medicine |
| Location | 795 El Camino Real, Palo Alto, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083627004 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | A43834 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jay Schlumpberger, MD 2350 W El Camino Real, 2nd Floor, Mountain View, CA 94040-6203 Ph: () - | Jay Schlumpberger, MD 795 El Camino Real, Palo Alto, CA 94301-2302 Ph: (650) 321-4121 |
News Archive
Avita Medical Ltd., a medical device company specializing in the treatment of wounds and skin defects, today said a branch of the U.S. Military says the U.S. Department of Defense ‘wants to use' the company's ReCell technology, which it described as offering a possible ‘paradigm shift' in skin injury treatment.
Researchers from the UC San Diego, School of Medicine and colleagues have identified a new gene, ETS-1, that is linked to human congenital heart defects. The landmark study, recently published online in the journal of Human Molecular Genetics, provides important insights into some of the most prevalent forms of congenital heart defects in humans, including ventricular septal defects and potentially hypoplastic left heart syndrome, a uniformly fatal heart abnormality.
According to a new study published in the Journal of the American Medical Association (JAMA) this week the accuracy of caloric counts from restaurants is unknown. On the same day, the Center for Science in the Public Interest released its annual ‘Xtreme Eating Awards' to eight menu items on the restaurant menus.
Researchers at the Institute of Biotechnology and Biomedicine, Universitat Autònoma de Barcelona (IBB-UAB), in collaboration with the biopharmaceutical company SOM Biotech, located in the Barcelona Science Park (PCB), have published, in Nature Communications, the results of a drug repositioning study in which they describe a powerful drug, SOM0226 (tolcapone) that could significantly improve the pharmacological treatment of familial transthyretin amyloidosis (ATTR).
› Verified 2 days ago
Dr. Ian J Nelligan, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 211 Quarry Rd, Palo Alto, CA 94304 Phone: 650-498-5409 | |
Sherry Huang, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 795 El Camino Real, Palo Alto, CA 94301 Phone: 650-853-2984 | |
Mary Hufty, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 795 El Camino Real, Palo Alto, CA 94301 Phone: 650-321-4121 | |
Tami Miller, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 795 El Camino Real, Palo Alto, CA 94301 Phone: 650-321-4121 | |
Dr. Diana Chen, MD, MBA Family Medicine Medicare: Medicare Enrolled Practice Location: 795 El Camino Real, Palo Alto, CA 94301 Phone: 650-321-4121 | |
Brett Spitnale, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 795 El Camino Real, Palo Alto, CA 94301 Phone: 650-853-2984 |